Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution

Abstract

AbstractObjective. To examine the association of the evolution in physician-reported and patient-reported outcomes with decision to stop biological DMARDs (bDM

Publication
Rheumatology, NA page NA